Levothyroxine Sodium Tablet
Product Images NDC 51655-604

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-604). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 604 52 Master Bottle Label Approval Rev B 04 21)

Label for Levothyroxine Sodium Tablets, USP 112 mcg (0.112 mg), oral tablets in a bottle of 30 count. The label includes dosage strength and quantity, prescription only status, storage instructions, and manufacturer information for Northwind Pharmaceuticals, Indianapolis, IN. The NDC is 51655-604-52.*

FDA Label Image

Levothyroxine Sodium Structural Formula (Image 13)

Chemical structure diagram of levothyroxine sodium. The diagram shows the molecular arrangement including iodine atoms, hydroxyl groups, aromatic rings, and sodium salt components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.